CDC107: A Protein with Potential as A Drug Target Or Biomarker

Target Name: CCDC107

NCBI ID: G203260

CCDC107

CDC107: A Protein with Potential as A Drug Target Or Biomarker

CCDC107 (CCDC107 variant A) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the C-type water-type transmembrane protein (TMP) family, which is characterized by the presence of a transmembrane domain and a N-terminus that is involved in protein-protein interactions.

One of the unique features of CCDC107 is its ability to interact with several different proteins, including the protein known as PDGF-BB (Platelet-derived growth factor-beta). This interaction between CCDC107 and PDGF-BB has been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival.

In addition to its interaction with PDGF-BB, CCDC107 has also been shown to interact with several other proteins, including the protein known as NF-kappa-B1 (nuclear factor-kB1). This interaction between CCDC107 and NF-kappa-B1 has been shown to play a role in the regulation of cellular processes such as inflammation, pain, and stress.

The unique combination of interactions between CCDC107 and PDGF-BB, as well as its interaction with NF-kappa-B1, makes it an attractive potential drug target. Researchers are currently working to develop small molecules that can specifically interact with CCDC107 and enhance its ability to interact with PDGF-BB and NF-kappa-B1. These small molecules may be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, CCDC107 is also being studied as a biomarker for several diseases. For example, CCDC107 has been shown to be elevated in the blood of individuals with pancreatic cancer, and may be used as a diagnostic marker for this disease. Additionally, CCDC107 has been shown to be elevated in the urine of individuals with neurodegenerative diseases, and may be used as a diagnostic marker for these conditions.

Overall, CCDC107 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Coiled-coil Domain Containing 107

The "CCDC107 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC107 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets